Literature DB >> 16567528

Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis.

Juris J Meier1, Lise L Kjems, Johannes D Veldhuis, Pierre Lefèbvre, Peter C Butler.   

Abstract

Type 2 diabetes is characterized by an approximately 60% loss of beta-cell mass, a marked defect in postprandial insulin secretion, and a failure to suppress postprandial glucagon concentrations. It is possible that postprandial hyperglucagonemia in type 2 diabetes is due to impaired postprandial insulin secretion. To address this, we studied eight adult Goettingen minipigs before and after an approximately 60% reduction in beta-cell mass induced by alloxan. Pigs were studied fasting and after ingestion of a mixed meal. Insulin and glucagon secretion were determined by deconvolution of blood hormone concentrations measured at 1-min intervals. The relationship between insulin and glucagon release was analyzed using cross-correlation and forward versus reverse cross-approximate entropy. We report that glucagon and insulin were secreted in approximately 4-min pulses. Prealloxan, postprandial insulin secretion drove an approximately 20% suppression of glucagon concentrations (P < 0.01), through inhibition of glucagon pulse mass. The alloxan-induced approximately 60% deficit in beta-cell mass lead to an approximately 70% deficit in postprandial insulin secretion and loss of the postprandial insulin-driven suppression of glucagon secretion. We conclude that postprandial hyperglucagonemia in type 2 diabetes is likely due to loss of intraislet postprandial suppression of glucagon secretion by insulin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567528     DOI: 10.2337/diabetes.55.04.06.db05-1449

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  45 in total

1.  Logistic model of glucose-regulated C-peptide secretion: hysteresis pathway disruption in impaired fasting glycemia.

Authors:  Daniel M Keenan; Rita Basu; Yan Liu; Ananda Basu; Gerlies Bock; Johannes D Veldhuis
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

Review 2.  Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.

Authors:  Philip E Cryer
Journal:  Endocrinology       Date:  2011-12-13       Impact factor: 4.736

3.  Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus.

Authors:  F K Knop; T Vilsbøll; S Madsbad; J J Holst; T Krarup
Journal:  Diabetologia       Date:  2007-01-16       Impact factor: 10.122

4.  Diminished glucagon suppression after β-cell reduction is due to impaired α-cell function rather than an expansion of α-cell mass.

Authors:  Juris J Meier; Sandra Ueberberg; Simone Korbas; Stephan Schneider
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-02-01       Impact factor: 4.310

Review 5.  Beta cell mass in diabetes: a realistic therapeutic target?

Authors:  J J Meier
Journal:  Diabetologia       Date:  2008-03-04       Impact factor: 10.122

Review 6.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

Review 7.  Paracrine signaling in islet function and survival.

Authors:  Sean M Hartig; Aaron R Cox
Journal:  J Mol Med (Berl)       Date:  2020-02-17       Impact factor: 4.599

8.  Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo.

Authors:  Sachin A Paranjape; Owen Chan; Wanling Zhu; Adam M Horblitt; Ewan C McNay; James A Cresswell; Jonathan S Bogan; Rory J McCrimmon; Robert S Sherwin
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

9.  Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans.

Authors:  Benjamin A Cooperberg; Philip E Cryer
Journal:  Diabetes Care       Date:  2009-09-03       Impact factor: 17.152

Review 10.  Pulsatility of insulin release--a clinically important phenomenon.

Authors:  Bo Hellman
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.